HER2-low status improves prognosis prediction in breast cancer patients receiving neoadjuvant treatment: A comparison of pathological stage, modified CPS+EG scoring system, and Neo-Bioscore.
- DOI
- 10.21147/j.issn.1000-9604.2024.06.10
- Published
- 2024-12-01
- Container
- Chin J Cancer Res
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21147/j.issn.1000-9604.2024.06.10,
title = {HER2-low status improves prognosis prediction in breast cancer patients receiving neoadjuvant treatment: A comparison of pathological stage, modified CPS+EG scoring system, and Neo-Bioscore.},
author = {Lu Y and Zhu S and Wu C and Fei X and Shen K and Chen X.},
year = {2024},
journal = {Chin J Cancer Res},
doi = {10.21147/j.issn.1000-9604.2024.06.10},
url = {https://doi.org/10.21147/j.issn.1000-9604.2024.06.10}
}RIS
TY - JOUR TI - HER2-low status improves prognosis prediction in breast cancer patients receiving neoadjuvant treatment: A comparison of pathological stage, modified CPS+EG scoring system, and Neo-Bioscore. AU - Lu Y AU - Zhu S AU - Wu C AU - Fei X AU - Shen K AU - Chen X. PY - 2024 JO - Chin J Cancer Res DO - 10.21147/j.issn.1000-9604.2024.06.10 UR - https://doi.org/10.21147/j.issn.1000-9604.2024.06.10 ER -
APA
Y, L., S, Z., C, W., X, F., K, S., & X., C. (2024). HER2-low status improves prognosis prediction in breast cancer patients receiving neoadjuvant treatment: A comparison of pathological stage, modified CPS+EG scoring system, and Neo-Bioscore.. Chin J Cancer Res. https://doi.org/10.21147/j.issn.1000-9604.2024.06.10
Source records
- europe-pmc · retrieved 2026-09-27T07:52:01.259Z